Literature DB >> 2432183

Dihydropyridine modulation of the chromaffin cell secretory response.

M G Ladona, D Aunis, L Gandía, A G García.   

Abstract

Prolonged perfusion of cat adrenal glands with Krebs-bicarbonate solutions containing nicotine, muscarine, or excess K rapidly increased the rate of catecholamine output proportional to the concentrations of secretagogue used. The secretory responses to nicotine or high K reached a peak and declined to almost basal rates of secretion after about 10 min of stimulation. The dihydropyridine Ca channel agonist Bay K 8644 potentiated markedly the secretory responses to 1 microM nicotine and to 17.7 mM K but not to higher concentrations of these secretagogues. The muscarinic response did not decrease with time and was modestly potentiated by Bay K 8644. Similar curves were obtained with 17.7 mM K plus Bay K 8644 and with 59 mM K alone. CGP28392, another agonist, was about 10 times less potent than Bay K 8644 in potentiating the secretory responses to 17.7 mM K. Bay K 8644 also potentiated the release of [3H]noradrenaline evoked by stimulation of cultured bovine adrenal chromaffin cells with 17.7 mM K or 2 microM nicotine but not with higher concentrations of K or nicotine. Dihydropyridine Ca channel antagonists reversed the effects of Bay K 8644 with the following order of potency: niludipine greater than nifedipine = nimodipine greater than nitrendipine. The secretory rates from intact chromaffin cells treated with the Ca ionophores X537A or A23187, or those evoked by Ca-EGTA buffers from digitonin-permeabilized cells, were not affected by Bay K 8644. These results are compatible with the following conclusions: Bay K 8644 selectively potentiates catecholamine secretory responses mediated through the activation of voltage-sensitive Ca channels; during nicotine or high-K stimulation, Ca gains access to the cell interior through a common permeability pathway, the Ca channel.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2432183     DOI: 10.1111/j.1471-4159.1987.tb04118.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Influence of ketamine on catecholamine secretion in the perfused rat adrenal medulla.

Authors:  Young-Yeob Ko; Yong-Hoon Jeong; Dong-Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2008-06-30       Impact factor: 2.016

2.  Voltage-dependent inactivation of catecholamine secretion evoked by brief calcium pulses in the cat adrenal medulla.

Authors:  B Garrido; M G López; M A Moro; R de Pascual; A G García
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

3.  (+)-isradipine but not (-)-Bay-K-8644 exhibits voltage-dependent effects on cat adrenal catecholamine release.

Authors:  M G López; P Michelena; L Gandía; A G García
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

4.  Multiple calcium channel subtypes in isolated rat chromaffin cells.

Authors:  L Gandía; R Borges; A Albillos; A G García
Journal:  Pflugers Arch       Date:  1995-05       Impact factor: 3.657

5.  Variable, voltage-dependent, blocking effects of nitrendipine, verapamil, diltiazem, cinnarizine and cadmium on adrenomedullary secretion.

Authors:  M G López; M A Moro; C F Castillo; C R Artalejo; A G García
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

6.  Ca(2+)-activated K+ channels modulate muscarinic secretion in cat chromaffin cells.

Authors:  G Uceda; A R Artalejo; M G López; F Abad; E Neher; A G García
Journal:  J Physiol       Date:  1992-08       Impact factor: 5.182

7.  The source of calcium for muscarinic-mediated catecholamine release from cat adrenals.

Authors:  F Abad; B Garrido; M G López; A G García
Journal:  J Physiol       Date:  1992-01       Impact factor: 5.182

8.  Calcium channel subtypes in cat chromaffin cells.

Authors:  A Albillos; A R Artalejo; M G López; L Gandía; A G García; E Carbone
Journal:  J Physiol       Date:  1994-06-01       Impact factor: 5.182

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.